Results 111 to 120 of about 1,685,677 (279)

Cognitive behavioral therapy for somatic symptom disorders in later life: a prospective comparative explorative pilot study in two clinical populations

open access: yes, 2017
Michelle JH Verdurmen,1 Arjan C Videler,2 Astrid M Kamperman,3 David Khasho,4 Christina M van der Feltz-Cornelis4,5 1Department of Personality Disorders, GGz Breburg, Tilburg, 2Department of Geriatric Psychiatry, GGz Breburg, Tilburg, 3Department of ...
Khasho D   +4 more
core  

Alzheimer's Disease Biomarkers Measured by Capillary Blood Collection Versus Venous Plasma and Cerebrospinal Fluid

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Blood biomarkers are increasingly critical for non‐invasive Alzheimer's Disease (AD) diagnostics and research but typically require on‐site processing. Remote point‐of‐care collection methods could enhance biomarker testing in clinical and research settings.
Sara Ho   +9 more
wiley   +1 more source

Somatic Symptoms as Idioms of Distress in East Asian Patients With Differing Temporomandibular Disorder Diagnostic Subtypes

open access: yesInternational Dental Journal
Objective: This cross-sectional study investigated the prevalence/severity of somatic symptoms, their relationship with psychological distress and oral behaviors in different temporomandibular disorder (TMD) diagnostic subtypes, and identified ...
Adrian Ujin Yap   +4 more
doaj   +1 more source

Subjective Cognitive Concerns and Cognitive Trajectories in Parkinson's Disease: Biomarker Impact

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To examine the relationship of subjective cognitive concerns (SCC) with biomarkers of Alzheimer's disease (AD), neurodegeneration, and Parkinson's disease (PD) and domain‐specific cognitive trajectories among cognitively unimpaired persons with de novo PD. Method Cognitively unimpaired participants with SCC (n = 294) and without SCC (
Francesca V. Lopez   +5 more
wiley   +1 more source

Somatic Symptom Disorders of Healthcare Workers

open access: yesЗдоровье мегаполиса
Introduction. Occupational stress leads health workers to somatic symptom disorders. Purpose. To identify somatic symptom disorders of healthcare workers. Methods and materials.
O. B. Polyakova, T. I. Bonkalo
doaj   +1 more source

Research on Somatization and Somatic Symptom Disorders [PDF]

open access: yes, 2017
The new Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition defines somatic symptom and related disorders as long-standing somatic symptoms that are associated with disproportionate thoughts, feelings, and behaviors, irrespective of whether or not a medical cause for these symptoms can be determined.
openaire   +1 more source

Body drawings as an assessment tool for body-relatedness in patients with severe somatic symptom disorder

open access: yes, 2015
Background: A core feature of somatic symptom disorder is the troubled relation of patients to their body. Efforts to assess body-relatedness have been focusing on self-report questionnaires, which may overlook important aspects of body-relatedness ...
van Broeckhuysen-Kloth, S.   +7 more
core  

The Impact of Expectations and Framing on the course of Symptom Severity in Somatic Symptom Disorder—Ecological Momentary Assessment from the SOMA.SSD Study

open access: yes
Purpose Symptom expectations are considered contributing mechanisms for underlying persistent somatic symptoms in somatic symptom disorder.
Henrike Wittenbecher   +6 more
core   +1 more source

Cerebrospinal Fluid Over Plasma Links Analytes to Cognitive Decline in Older Adults at Risk for Alzheimer's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To identify inflammatory analytes in cerebrospinal fluid (CSF) and plasma associated with cognitive decline in cognitively normal (CN) older adults at risk for Alzheimer's disease (AD). Methods In a longitudinal study of 118 CN older adults (65–80 years, 54% APOE ε4, 26% preclinical AD), 1331 CSF and 1501 plasma analytes were ...
Jagan A. Pillai   +13 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source

Home - About - Disclaimer - Privacy